Document Detail


Enrichment of rare cancer cells through depletion of normal cells using density and flow-through, immunomagnetic cell separation.
MedLine Citation:
PMID:  15504544     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To develop a reliable technique to enrich for rare cells in blood suspensions using only negative selection steps including a flow-through immunomagnetic cell separations system and by optimizing variables normally encountered during such enrichment processes. METHODS: A human breast cancer cell line was cultivated and spiked at a ratio of 1 cancer cell to 10(5) total leukocytes in buffy coat or 1 cancer cell to 10(8) total cells in whole blood samples. The final, optimized process consisted of: a red cell lysis step, immunomagnetically staining leukocytes with an anti-CD45 PE, anti- MACS sandwich, immunomagnetic sorting using a flow-through system (QMS), and a final cell analysis step using either an automated cell counter, filtration, and visual counting or a cytospin analysis. RESULTS: The final, optimized process produced a final enrichment of the rare cancer cells of 5.17 log(10) and an average, final recovery of 46%. It should be noted that a negative depletion protocol was used (i.e., no labeling of the rare cancer cells was used). CONCLUSIONS: To the authors' knowledge, no examples in the literature exist of a 5.17 log(10) enrichment of cancer cells in human blood using a negative depletion protocol. The closest example is a 4 log(10) enrichment in which two positive magnetic cell separation steps were used (none were used in this study). Ongoing studies are investigating further modifications of the precommercial, prototype flow-through immunmagnetic separation system to increase both the enrichment and recovery rate. However, even at current performance levels, the presented process could significantly improve visual and molecular analysis of rare cells in blood.
Authors:
Oscar Lara; Xiaodong Tong; Maciej Zborowski; Jeffrey J Chalmers
Related Documents :
17635654 - Centrifugation of bacterial cells on slide surface improves the spatial distribution, c...
25287204 - Analysis of the conductivity of plasmodesmata by microinjection.
884704 - Cell cycle time determinations based on liquid scintillation counting of 3h-tdr labeled...
12054134 - Evaluation of measurements of the conductivity of quarter milk samples for the early di...
15080744 - Autonomous multielectrode system for monitoring the interactions of isoflavonoids with ...
16488094 - An experimental in vitro model for dynamic direct exposure of human cells to airborne c...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Experimental hematology     Volume:  32     ISSN:  0301-472X     ISO Abbreviation:  Exp. Hematol.     Publication Date:  2004 Oct 
Date Detail:
Created Date:  2004-10-26     Completed Date:  2004-12-16     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0402313     Medline TA:  Exp Hematol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  891-904     Citation Subset:  IM    
Affiliation:
Department of Chemical and Biomolecular Engineering, The Ohio State University, Columbus, Ohio, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antibodies, Monoclonal / immunology
Antigens, CD45 / immunology
Blood Cells
Cell Line, Tumor
Cell Size
Equipment Design
Humans
Immunomagnetic Separation / instrumentation*,  methods*
Methods
Neoplasms / pathology*
Tumor Markers, Biological / immunology
Grant Support
ID/Acronym/Agency:
P30 CA16058/CA/NCI NIH HHS; R01 CA62349/CA/NCI NIH HHS; R01 CA97391-01A1/CA/NCI NIH HHS; R33 CA81662-01/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/Tumor Markers, Biological; EC 3.1.3.48/Antigens, CD45

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The hemangioblast: cradle to clinic.
Next Document:  Osteosclerosis in idiopathic myelofibrosis is related to the overproduction of osteoprotegerin (OPG)...